Are Skin Lesion Superclinics Associated With Decision Fatigue? A Controlled, Observational Study.

IF 3.7 4区医学 Q1 DERMATOLOGY

Clinical and Experimental Dermatology Pub Date : 2025-06-23 DOI:10.1093/ced/llaf287

Huw W S Greenish, Hafsa Faarax Shirwac, Hannah Morgan, Harry Heath, Emma Porter, Sarah Carswell, Chloe White, Neha Kasaravalli, Alexander D G Anderson

{"title":"Are Skin Lesion Superclinics Associated With Decision Fatigue? A Controlled, Observational Study.","authors":"Huw W S Greenish, Hafsa Faarax Shirwac, Hannah Morgan, Harry Heath, Emma Porter, Sarah Carswell, Chloe White, Neha Kasaravalli, Alexander D G Anderson","doi":"10.1093/ced/llaf287","DOIUrl":null,"url":null,"abstract":"<p><p>Skin cancer superclinics have been proposed as an innovative solution to current capacity shortfalls. The aim of this study was to investigate whether this model was associated with decision fatigue. Consecutive patients with suspected skin cancer who attended a superclinic in 2022 were compared with those seen by the same clinician in standard clinics. Proxy markers of decision fatigue were cancer pickup rates and proportion of patients discharged without histology following initial clinic visit. 100/345 (29.0%) patients seen in superclinics had an ultimate diagnosis of skin malignancy, vs. 161/588 (27.4%) seen in standard clinic (p=0.598). 162 (47.0%) of superclinic patients were discharged without intervention vs. 294 (50.0%%) of patients in the standard clinic group (p=0.369). The superclinic model did not appear to be associated with decision fatigue in the one clinician studied and proved a safe and effective means of providing clinical care, improving capacity and delivering training.</p>","PeriodicalId":10324,"journal":{"name":"Clinical and Experimental Dermatology","volume":" ","pages":""},"PeriodicalIF":3.7000,"publicationDate":"2025-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Experimental Dermatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ced/llaf287","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"DERMATOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Skin cancer superclinics have been proposed as an innovative solution to current capacity shortfalls. The aim of this study was to investigate whether this model was associated with decision fatigue. Consecutive patients with suspected skin cancer who attended a superclinic in 2022 were compared with those seen by the same clinician in standard clinics. Proxy markers of decision fatigue were cancer pickup rates and proportion of patients discharged without histology following initial clinic visit. 100/345 (29.0%) patients seen in superclinics had an ultimate diagnosis of skin malignancy, vs. 161/588 (27.4%) seen in standard clinic (p=0.598). 162 (47.0%) of superclinic patients were discharged without intervention vs. 294 (50.0%%) of patients in the standard clinic group (p=0.369). The superclinic model did not appear to be associated with decision fatigue in the one clinician studied and proved a safe and effective means of providing clinical care, improving capacity and delivering training.

查看原文本刊更多论文

皮肤病变超级诊所与决策疲劳有关吗？一项对照观察性研究。

皮肤癌超级诊所被提议作为解决目前能力不足的创新解决方案。本研究的目的是调查该模型是否与决策疲劳有关。研究人员将2022年在超级诊所连续就诊的疑似皮肤癌患者与同一名临床医生在标准诊所就诊的患者进行了比较。决策疲劳的替代指标是癌症拾起率和初次就诊后未作组织学检查出院的患者比例。超级诊所的100/345（29.0%）患者最终诊断为皮肤恶性肿瘤，而标准诊所的161/588（27.4%）患者最终诊断为皮肤恶性肿瘤（p=0.598）。超临床组162例（47.0%）无干预出院，标准临床组294例（50.0%）无干预出院（p=0.369）。在一名临床医生的研究中，超级诊所模式似乎与决策疲劳无关，并被证明是提供临床护理、提高能力和提供培训的安全有效的手段。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical and Experimental Dermatology 医学-皮肤病学

CiteScore

3.20

自引率

2.40%

发文量

389

审稿时长

3-8 weeks

期刊介绍： Clinical and Experimental Dermatology (CED) is a unique provider of relevant and educational material for practising clinicians and dermatological researchers. We support continuing professional development (CPD) of dermatology specialists to advance the understanding, management and treatment of skin disease in order to improve patient outcomes.